logo

For the Inventor, By the Inventor

Frankfurt, Germany

Maike Glien

This inventor holds 17 USPTO granted patents and 13 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Sanofi-Aventis, Sanofi, Sanofi-A Ventis Deutschland Gmbh. Active years: 2008-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maike Glien. Retrieved from https://idiyas.com/inventor/maike-glien

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17

% Patents Active = 5.9

 

Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 30(Granted Patents)


Location History:

  • Wiesbaden, DE (2008 - 2010)
  • Frankfurt-am-Main, DE (2009 - 2015)

Company Filing History:

goldMedal12 out of 390 
 
Sanofi-Aventis
 patents
silverMedal3 out of 1,547 
 
Sanofi
 patents
bronzeMedal2 out of 1,855 
 
Sanofi-A Ventis Deutschland Gmbh
 patents

Years Active: 2008-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
Sulfonamides
Oxadiazolone
Thiadiazole
Pharmaceutical Compositions
Amino-Oxazoles
Peroxisome Proliferator
Cyclic Compounds
Bicyclic Amides
Drug Development
Therapeutic Applications
Pharmaceutical Processes
Chemical Derivatives
17 patents (USPTO):Explore Patents
1. 8946212 - Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals (2015-02-03),
2. 8716317 - Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals (2014-05-06),
3. 8344004 - Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals (2013-01-01),
4. 8329725 - Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals (2012-12-11),
5. 8173674 - Sulfonyl-phenyl-2H-[1,2,4]oxadiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals (2012-05-08),
6. 7910612 - 4-oxy-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for their therapeutic use (2011-03-22),
7. 7858647 - N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions thereof and methods for their therapeutic use (2010-12-28),
8. 7851493 - Phenyl-1,2,4-oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals (2010-12-14),
9. 7834030 - Phenyl-[1,2,4]-oxadiazol-5-one derivatives, pharmaceutical compositions and therapeutic use thereof (2010-11-16),
10. 7772257 - Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their use (2010-08-10),
11. 7709509 - Oxadiazolones and derivatives thereof as peroxisome proliferator-activated receptor (PPAR) delta agonists (2010-05-04),
12. 7709481 - Phenyl-1,2,4-oxadiazolone derivatives, processes for their preparation and methods for their use as pharmaceuticals (2010-05-04),
13. 7683181 - Cyclic N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for the therapeutic use thereof (2010-03-23),
14. 7655679 - Derivatives of 2-aminothiazoles and 2-amino-oxazoles, processes for their preparation and their use as pharmaceutical compositions (2010-02-02),
15. 7612104 - Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their use (2009-11-03),

Title: Inventor Maike Glien - Revolutionizing Technology in Frankfurt am Main

Introduction: Maike Glien is a visionary inventor based in Frankfurt am Main, Germany, known for her groundbreaking contributions to the field of technology.

Latest Patents: Maike Glien holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing her commitment to innovation and sustainability.

Career Highlights: With a background in engineering and a passion for creating solutions to complex problems, Maike Glien has led numerous projects that have pushed the boundaries of technological advancements.

Collaborations: Throughout her career, Maike Glien has collaborated with leading research institutions, universities, and tech companies to bring her inventions to life, fostering a culture of innovation and collaboration in the industry.

Conclusion: Maike Glien's dedication to innovation and her relentless pursuit of technological advancement make her a prominent figure in the world of inventors, inspiring the next generation of innovators to push the limits of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…